Li. Boone et al., USE OF HUMAN RECOMBINANT ERYTHROPOIETIN AND PREDNISONE FOR TREATMENT OF MYELODYSPLASTIC SYNDROME WITH ERYTHROID PREDOMINANCE IN A DOG, Journal of the American Veterinary Medical Association, 213(7), 1998, pp. 999
The term ''myelodysplastic syndrome'' refers to any of a group of myel
oproliferative disorders characterized by anemia, neutropenia, or thro
mbocytopenia accompanied by dysplasia of the hematopoietic stem cells
in bone marrow, with blast cells comprising less than 30% of the nucle
ated cell population in bone marrow. Administration of erythropoietin
may be useful in the management of refractory anemia associated with m
yelodysplastic syndrome in dogs.